BDBM316162 2-{[3-({5-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl)ureido]pyridine-2-yl}ethynyl)-1H-indazol-6-yl]thio}-N-methylbenzamide ::US9617222, Compound 37
SMILES: CNC(=O)c1ccccc1Sc1ccc2c(n[nH]c2c1)C#Cc1ccc(NC(=O)NCCOCCOCCOCCOCCOC)cn1
InChI Key: InChIKey=JBRNVUSGLAFGQA-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human)) | BDBM316162 (2-{[3-({5-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | n/a | n/a |
SENJU PHARMACEUTICAL CO., LTD. US Patent | Assay Description Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t... | US Patent US9617222 (2017) BindingDB Entry DOI: 10.7270/Q2FN189X | |||||||||||
More data for this Ligand-Target Pair |